Simon Jochum

1.3k total citations
12 papers, 606 citations indexed

About

Simon Jochum is a scholar working on Infectious Diseases, Oncology and Epidemiology. According to data from OpenAlex, Simon Jochum has authored 12 papers receiving a total of 606 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 5 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Simon Jochum's work include SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (6 papers) and Viral-associated cancers and disorders (5 papers). Simon Jochum is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (6 papers), COVID-19 Clinical Research Studies (6 papers) and Viral-associated cancers and disorders (5 papers). Simon Jochum collaborates with scholars based in Germany, United States and Switzerland. Simon Jochum's co-authors include Reinhard Zeidler, Wolfgang Hammerschmidt, Stephan Lang, Andreas Moosmann, Pauline Wimberger, Ulrich Welsch, Ralph Mocikat, G. Reisbach, Gerhard Wanner and Giulia Torriani and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Journal of Virology.

In The Last Decade

Simon Jochum

12 papers receiving 599 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Simon Jochum Germany 8 232 219 192 174 134 12 606
Dhananjay M. Nawandar United States 11 143 0.6× 424 1.9× 73 0.4× 156 0.9× 186 1.4× 13 595
Kevin J. Gilligan United States 10 236 1.0× 488 2.2× 245 1.3× 91 0.5× 202 1.5× 12 794
Shantan Reddy United States 12 299 1.3× 386 1.8× 81 0.4× 91 0.5× 42 0.3× 16 709
Ben X. Wang Canada 9 128 0.6× 190 0.9× 98 0.5× 246 1.4× 61 0.5× 33 511
Zhi Q. Yao United States 13 163 0.7× 122 0.6× 50 0.3× 222 1.3× 203 1.5× 21 555
Matthew P. Mulè United States 10 196 0.8× 105 0.5× 60 0.3× 259 1.5× 79 0.6× 14 521
Ioan Filip United States 10 90 0.4× 128 0.6× 105 0.5× 126 0.7× 115 0.9× 14 429
Elisa Rosati Germany 8 157 0.7× 135 0.6× 73 0.4× 292 1.7× 43 0.3× 14 481
Nicholas N. Jarjour United States 11 141 0.6× 95 0.4× 125 0.7× 385 2.2× 57 0.4× 16 601
Andrew Medvec United States 8 134 0.6× 326 1.5× 103 0.5× 455 2.6× 87 0.6× 8 736

Countries citing papers authored by Simon Jochum

Since Specialization
Citations

This map shows the geographic impact of Simon Jochum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Jochum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Jochum more than expected).

Fields of papers citing papers by Simon Jochum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Jochum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Jochum. The network helps show where Simon Jochum may publish in the future.

Co-authorship network of co-authors of Simon Jochum

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Jochum. A scholar is included among the top collaborators of Simon Jochum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Jochum. Simon Jochum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Yang, Fei, et al.. (2024). SARS-CoV-2 SPIKE Antibody Levels can Indicate Immuno-Resilience to Re-infection: a Real-World Study. Infectious Diseases and Therapy. 14(1). 229–243. 1 indexed citations
2.
Patrone, Paul N., Anthony J. Kearsley, Adolfas K. Gaigalas, et al.. (2023). Monoclonal Antibodies as SARS-CoV-2 Serology Standards: Experimental Validation and Broader Implications for Correlates of Protection. International Journal of Molecular Sciences. 24(21). 15705–15705. 2 indexed citations
3.
Potapov, Sergej, et al.. (2022). Design and performance characteristics of the Elecsys anti-SARS-CoV-2 S assay. Frontiers in Immunology. 13. 1002576–1002576. 11 indexed citations
4.
Jochum, Simon, et al.. (2022). Clinical Utility of Elecsys Anti-SARS-CoV-2 S Assay in COVID-19 Vaccination: An Exploratory Analysis of the mRNA-1273 Phase 1 Trial. Frontiers in Immunology. 12. 798117–798117. 39 indexed citations
5.
Grunert, Veit Peter, Holly Legault, Maha Maglinao, et al.. (2022). Quantifying the Vaccine-Induced Humoral Immune Response to Spike-Receptor Binding Domain as a Surrogate for Neutralization Testing Following mRNA-1273 (Spikevax) Vaccination Against COVID-19. Infectious Diseases and Therapy. 12(1). 177–191. 5 indexed citations
6.
Schulte-Spechtel, Ulrike, et al.. (2021). Analytical performance evaluation of the Elecsys Epstein-Barr virus immunoassay panel. Diagnostic Microbiology and Infectious Disease. 101(3). 115443–115443. 2 indexed citations
7.
Jochum, Simon, Beatus Ofenloch-Haehnle, Michael Hombach, et al.. (2020). Development and Validation of the Elecsys Anti-SARS-CoV-2 Immunoassay as a Highly Specific Tool for Determining Past Exposure to SARS-CoV-2. Journal of Clinical Microbiology. 58(10). 92 indexed citations
8.
Jochum, Simon, et al.. (2012). RNAs in Epstein–Barr virions control early steps of infection. Proceedings of the National Academy of Sciences. 109(21). E1396–404. 65 indexed citations
9.
Jochum, Simon, Andreas Moosmann, Stephan Lang, Wolfgang Hammerschmidt, & Reinhard Zeidler. (2012). The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination. PLoS Pathogens. 8(5). e1002704–e1002704. 128 indexed citations
10.
Welsch, Ulrich, et al.. (2011). Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC. Cancer Immunology Immunotherapy. 60(5). 639–648. 124 indexed citations
11.
12.
Jochum, Simon, et al.. (2011). A Virus-Like Particle-Based Epstein-Barr Virus Vaccine. Journal of Virology. 85(24). 13105–13113. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dhananjay M. Nawandar Breakdown of academic impact, for papers by Kevin J. Gilligan Breakdown of academic impact, for papers by Shantan Reddy Breakdown of academic impact, for papers by Ben X. Wang Breakdown of academic impact, for papers by Zhi Q. Yao Breakdown of academic impact, for papers by Matthew P. Mulè Breakdown of academic impact, for papers by Ioan Filip Breakdown of academic impact, for papers by Elisa Rosati Breakdown of academic impact, for papers by Nicholas N. Jarjour Breakdown of academic impact, for papers by Andrew Medvec
Rankless by CCL
2026